Cargando…

Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis

BACKGROUND: Smoking impairs lung immune function and damages upper airways, increasing risks of contracting and severity of infectious diseases. This paper quantifies the association between smoking and COVID-19 disease progression. METHODS: We searched PubMed and Embase for studies published from J...

Descripción completa

Detalles Bibliográficos
Autores principales: Patanavanich, Roengrudee, Glantz, Stanton A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366155/
https://www.ncbi.nlm.nih.gov/pubmed/34399729
http://dx.doi.org/10.1186/s12889-021-11579-x
_version_ 1783738854438600704
author Patanavanich, Roengrudee
Glantz, Stanton A.
author_facet Patanavanich, Roengrudee
Glantz, Stanton A.
author_sort Patanavanich, Roengrudee
collection PubMed
description BACKGROUND: Smoking impairs lung immune function and damages upper airways, increasing risks of contracting and severity of infectious diseases. This paper quantifies the association between smoking and COVID-19 disease progression. METHODS: We searched PubMed and Embase for studies published from January 1–May 25, 2020. We included studies reporting smoking behavior of COVID-19 patients and progression of disease, including death. We used random effects meta-analysis, meta-regression and locally weighted regression and smoothing to examine relationships in the data. RESULTS: We identified 46 peer-reviewed papers with a total of 22,939 COVID-19 patients, 5421 (23.6%) experienced disease progression and 2914 (12.7%) with a history of smoking (current and former smokers). Among those with a history of smoking, 33.5% experienced disease progression, compared with 21.9% of non-smokers. The meta-analysis confirmed an association between ever smoking and COVID-19 progression (OR 1.59, 95% CI 1.33–1.89, p = 0.001). Ever smoking was associated with increased risk of death from COVID-19 (OR 1.19, 95% CI 1.02–1.39, p = 0.003). We found no significant difference (p = 0.864) between the effects of ever smoking on COVID-19 disease progression between adjusted and unadjusted analyses, suggesting that smoking is an independent risk factor for COVID-19 disease progression. We also found the risk of having COVID-19 progression higher among younger adults (p = 0.001), with the effect most pronounced among younger adults under about 45 years old. CONCLUSIONS: Smoking is an independent risk for having progression of COVID-19, including mortality. The effects seem to be higher among young people. Smoking prevention and cessation should remain a priority for the public, physicians, and public health professionals during the COVID-19 pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-11579-x.
format Online
Article
Text
id pubmed-8366155
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83661552021-08-16 Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis Patanavanich, Roengrudee Glantz, Stanton A. BMC Public Health Research Article BACKGROUND: Smoking impairs lung immune function and damages upper airways, increasing risks of contracting and severity of infectious diseases. This paper quantifies the association between smoking and COVID-19 disease progression. METHODS: We searched PubMed and Embase for studies published from January 1–May 25, 2020. We included studies reporting smoking behavior of COVID-19 patients and progression of disease, including death. We used random effects meta-analysis, meta-regression and locally weighted regression and smoothing to examine relationships in the data. RESULTS: We identified 46 peer-reviewed papers with a total of 22,939 COVID-19 patients, 5421 (23.6%) experienced disease progression and 2914 (12.7%) with a history of smoking (current and former smokers). Among those with a history of smoking, 33.5% experienced disease progression, compared with 21.9% of non-smokers. The meta-analysis confirmed an association between ever smoking and COVID-19 progression (OR 1.59, 95% CI 1.33–1.89, p = 0.001). Ever smoking was associated with increased risk of death from COVID-19 (OR 1.19, 95% CI 1.02–1.39, p = 0.003). We found no significant difference (p = 0.864) between the effects of ever smoking on COVID-19 disease progression between adjusted and unadjusted analyses, suggesting that smoking is an independent risk factor for COVID-19 disease progression. We also found the risk of having COVID-19 progression higher among younger adults (p = 0.001), with the effect most pronounced among younger adults under about 45 years old. CONCLUSIONS: Smoking is an independent risk for having progression of COVID-19, including mortality. The effects seem to be higher among young people. Smoking prevention and cessation should remain a priority for the public, physicians, and public health professionals during the COVID-19 pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-11579-x. BioMed Central 2021-08-16 /pmc/articles/PMC8366155/ /pubmed/34399729 http://dx.doi.org/10.1186/s12889-021-11579-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Patanavanich, Roengrudee
Glantz, Stanton A.
Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis
title Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis
title_full Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis
title_fullStr Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis
title_full_unstemmed Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis
title_short Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis
title_sort smoking is associated with worse outcomes of covid-19 particularly among younger adults: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366155/
https://www.ncbi.nlm.nih.gov/pubmed/34399729
http://dx.doi.org/10.1186/s12889-021-11579-x
work_keys_str_mv AT patanavanichroengrudee smokingisassociatedwithworseoutcomesofcovid19particularlyamongyoungeradultsasystematicreviewandmetaanalysis
AT glantzstantona smokingisassociatedwithworseoutcomesofcovid19particularlyamongyoungeradultsasystematicreviewandmetaanalysis